MUMBAI, India, June 24 -- Intellectual Property India has published a patent application (202617059644 A) filed by Enkang Pharmaceuticals Guangzhou, Ltd. on May 11, 2026, for Compound Suitable For External Use, And Pharmaceutical Composition.
Inventors include Liang, Chun; Liu, Xiaorou; Song, Guoqiang; Huang, Qijian; and Su, Huanpeng.
The application for the patent was published on June 12, 2026, under issue no. 24/2026.
Abstract: A compound suitable for external use, and a pharmaceutical composition. The pharmaceutical composition comprises 17ß-neriifolin or a pharmaceutically acceptable salt, racemate, stereoisomer, enantiomer, diastereomer, tautomer, metabolite, solvate, and prodrug thereof as active ingredients, and has a good therapeutic effect on skin cancer or precancerous lesions thereof, particularly on cutaneous squamous cell carcinoma and basal skin cancer.
Disclaimer: Curated by HT Syndication.
